Gregor Diagnostics
3 employees
Biotech/Pharma
Series A · $14.6M
Open positions (1)
Company details
Team Size3
IndustryBiotech/Pharma
Funding
Total raised
$14.6M
Last stage
Series A
Investors
Total raised
$14.6M
Last stage
Series A
Investors
Tobias Zutz
Tobias Zutz is the CTO and Founder of Gregor Diagnostics, a molecular diagnostics company developing a novel screening test for prostate cancer using seminal fluid. He licensed the technology from WARF to found the company.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.